- Home
- AEVA vs QURE Comparison
AEVA vs QURE Comparison
Compare AEVA & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AEVA | QURE |
|---|---|---|
| Founded | 2019 | 1998 |
| Country | United States | Netherlands |
| Employees | 276 | 248 |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 819.5M | 663.4M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | AEVA | QURE |
|---|---|---|
| Price | $15.47 | $16.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 14 |
| Target Price | $26.50 | ★ $45.42 |
| AVG Volume (30 Days) | 1.5M | ★ 4.7M |
| Earning Date | 01-01-0001 | 06-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $13,107,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $132.72 | $395.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.90 | $7.76 |
| 52 Week High | $38.79 | $71.50 |
Technical Indicators
Market Signals| Indicator | AEVA | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 56.07 | 44.35 |
| Support Level | $12.28 | $13.29 |
| Resistance Level | $18.19 | $16.62 |
| Average True Range (ATR) | 1.33 | 2.07 |
| MACD | 0.22 | 0.29 |
| Stochastic Oscillator | 54.69 | 44.68 |
Price Performance
Historical ComparisonAbout AEVA Aeva Technologies Inc.
Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.